[HTML][HTML] Диагностика и лечение тромбоэмболии лёгочной артерии: клинические рекомендации Евразийской ассоциации кардиологов для практических …
ЕП Панченко, ТВ Балахонова… - Евразийский …, 2021 - cyberleninka.ru
Отказ от ответственности. Рекомендации ЕАК отражают точку зрения ЕАК и были
подготовлены после тщательного изучения научных и медицинских данных …
подготовлены после тщательного изучения научных и медицинских данных …
Indefinite anticoagulant therapy for first unprovoked venous thromboembolism: a cost-effectiveness study
Background: Clinical practice guidelines recommend indefinite anticoagulation for a first
unprovoked venous thromboembolism (VTE). Objective: To estimate the benefit–harm …
unprovoked venous thromboembolism (VTE). Objective: To estimate the benefit–harm …
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
G Palareti, D Poli, W Ageno, C Legnani… - Blood …, 2022 - ashpublications.org
D-dimer assay is used to stratify patients with unprovoked venous thromboembolism (VTE)
for the risk of recurrence. However, this approach was never evaluated since direct oral …
for the risk of recurrence. However, this approach was never evaluated since direct oral …
[HTML][HTML] Direct oral anticoagulants after bariatric surgery—what is the evidence?
Background Obesity is a global epidemic and bariatric surgery is used with increasing
frequency to treat its complications. The extent to which bariatric surgery alters the efficacy …
frequency to treat its complications. The extent to which bariatric surgery alters the efficacy …
[HTML][HTML] Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the Russian Association of Gerontologists and Geriatricians and the …
ON Tkacheva, NM Vorobyeva… - Cardiovascular …, 2021 - cardiovascular.elpub.ru
Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the
Russian Association of Gerontologists and Geriatricians and the National Society of Preventive …
Russian Association of Gerontologists and Geriatricians and the National Society of Preventive …
[HTML][HTML] Reduced‐dose direct oral anticoagulants in the extended treatment of venous thromboembolism: a systematic review and meta‐analysis
L Vasanthamohan, K Boonyawat… - Journal of Thrombosis …, 2018 - Elsevier
Essentials• In venous thromboembolism (VTE), benefits of extended treatment are balanced
by bleeding risks.• This is a meta‐analysis of reduced‐dose direct oral anticoagulants …
by bleeding risks.• This is a meta‐analysis of reduced‐dose direct oral anticoagulants …
[HTML][HTML] Anticoagulant‐associated gastrointestinal bleeding: Framework for decisions about whether, when and how to resume anticoagulants
Gastrointestinal (GI) bleeding is the most frequent single site of oral anticoagulant (OAC)‐
associated major bleeding. Patients with major GI bleeding experience morbidity and a …
associated major bleeding. Patients with major GI bleeding experience morbidity and a …
Venous thromboembolism in multiple myeloma–choice of prophylaxis, role of direct oral anticoagulants and special considerations
D Swan, A Rocci, C Bradbury… - British Journal of …, 2018 - Wiley Online Library
Multiple myeloma is associated with a significant risk of venous thromboembolism (VTE),
causing substantial levels of morbidity and mortality. The thrombogenicity of myeloma is …
causing substantial levels of morbidity and mortality. The thrombogenicity of myeloma is …
Bleeding in patients with gastrointestinal cancer compared with nongastrointestinal cancer treated with apixaban, rivaroxaban, or enoxaparin for acute venous …
DE Houghton, DT Vlazny, AI Casanegra… - Mayo Clinic …, 2021 - Elsevier
Objective To compare the bleeding risk in patients with gastrointestinal (GI) cancer with that
in patients with non-GI cancer treated with anticoagulation for acute cancer-associated …
in patients with non-GI cancer treated with anticoagulation for acute cancer-associated …
Risk of intracranial hemorrhage with direct oral anticoagulants: a systematic review and meta-analysis of randomized controlled trials
T Wu, C Lv, L Wu, W Chen, M Lv, S Jiang, J Zhang - Journal of neurology, 2022 - Springer
Objective We performed a systematic review and meta-analysis to compare the risk of
intracranial hemorrhage (ICH) between direct oral anticoagulants (DOACs) and other …
intracranial hemorrhage (ICH) between direct oral anticoagulants (DOACs) and other …